{
    "clinical_study": {
        "@rank": "102481", 
        "arm_group": {
            "arm_group_label": "Personal Heart Rhythm Monitor", 
            "arm_group_type": "Other", 
            "description": "Automated Cardiac Event Recorder in parallel with Personal Heart Rhythm Monitor."
        }, 
        "brief_summary": {
            "textblock": "This propsective study aims to compare the diagnostic yield of a Personal Heart Rhythm\n      Monitor (PHRM) with an automated cardiac  event recorder (ACER) to detect paroxysmal Atrial\n      Fibrillation PAF). The investigators hypothesise that the PHRM, used intermittently for 3\n      months, will detect significantly more cases of PAF than the ACER, used continuously for one\n      week.\n\n      A case-control sub-study will identify individuals with confirmed PAF, and matched\n      individuals with no evidence of PAF, to identify potential serum biomarkers for PAF.\n\n      A further case-control study will assess markers of left atrial function in patients with\n      PAF and their matched controls.\n\n      Another case-control sub-study will determine the significance of frequent Atrial Premature\n      Beats (APBs) in the development of AF over a one year period."
        }, 
        "brief_title": "Using a Personal Heart Rhythm Monitor to Diagnose Paroxsymal Atrial Fibrillation in the Community", 
        "completion_date": {
            "#text": "October 2015", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Paroxysmal Atrial Fibrillation", 
            "Stroke"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Atrial Fibrillation", 
                "Stroke"
            ]
        }, 
        "detailed_description": {
            "textblock": "Patients with suspected AF will be initially referred to a community-based, nurse-led\n      Arrhythmia clinic by their General Practitioners over a 15-month period.\n\n      All patients will be issued with a one week ACER (the 'R. Test 4 Evolution'), seen as the\n      'best-practice' investigation for this population group.  Participants will also be issued\n      with a PHRM for three months.  They will be instructed to take regular twice-daily, 30\n      second recordings with additional recordings in the event of relevant symptoms.  They will\n      return the ACER after one week and the PHRM after 3 months.\n\n      A subgroup of participants (target recruitment number = 100) will undergo transthoracic\n      echocardiography. A 40ml venous blood sample will also be taken.  Another small subgroup\n      (target recruitment = 20) will be asked to continue twice-daily recordings using the PHRM\n      for a further nine months and will be issued with a repeat one week ACER at study\n      completion."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Suspected paroxysmal AF (either palpitations consistent with AF or an irregular\n             pulse)\n\n          -  12-lead resting ECG confirming sinus rhythm\n\n          -  Capacity to consent to study\n\n          -  English-speaking\n\n          -  Life expectancy at least one year\n\n        Exclusion Criteria:\n\n          -  Previous diagnosis of AF\n\n          -  Recent history of syncope\n\n          -  Recent history of cardiac-sounding chest pain\n\n          -  A resting ECG suggestive of alternative arrhythmia\n\n          -  Inability to use the telephone\n\n          -  Thyrotoxicosis"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "N/A", 
            "minimum_age": "65 Years"
        }, 
        "enrollment": {
            "#text": "900", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "May 29, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01867060", 
            "org_study_id": "HASTE-2"
        }, 
        "intervention": [
            {
                "arm_group_label": "Personal Heart Rhythm Monitor", 
                "description": "Automated Cardiac Event Recorder to be worn continuously for one week.", 
                "intervention_name": "Automated Cardiac Event Recorder", 
                "intervention_type": "Device", 
                "other_name": "'R. Test Evolution 4' (Novacor)."
            }, 
            {
                "arm_group_label": "Personal Heart Rhythm Monitor", 
                "description": "Personal Heart Rhythm Monitor to be used twice-daily for three months.", 
                "intervention_name": "Personal Heart Rhythm Monitor", 
                "intervention_type": "Device", 
                "other_name": "'Portable ECG monitor HCG-801' (OMRON Healthcare)."
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": [
            "Cardiac monitoring", 
            "Biomarkers", 
            "Transthoracic echocardiography"
        ], 
        "lastchanged_date": "May 20, 2014", 
        "link": [
            {
                "description": "HASTE charity website", 
                "url": "http://www.haste.uk.com"
            }, 
            {
                "description": "HASTE Academy website", 
                "url": "http://www.hasteacademy.org"
            }
        ], 
        "location": {
            "contact": {
                "email": "philippah@doctors.org.uk", 
                "last_name": "Philippa J Howlett, MBChB BSc MRCP"
            }, 
            "facility": {
                "address": {
                    "city": "Guildford", 
                    "country": "United Kingdom", 
                    "state": "Surrey", 
                    "zip": "GU2 7XX"
                }, 
                "name": "Royal Surrey County Hospital NHS Foundation Trust"
            }, 
            "investigator": [
                {
                    "last_name": "Edward W Leatham, MBChB MD", 
                    "role": "Principal Investigator"
                }, 
                {
                    "last_name": "Philippa J Howlett, MBChB BSc", 
                    "role": "Sub-Investigator"
                }
            ], 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "United Kingdom"
        }, 
        "number_of_arms": "1", 
        "official_title": "Using a Personal Heart Rhythm Monitor (PHRM) to Diagnose Paroxsymal Atrial Fibrillation (PAF) in the Community - Substudies to Investigate Biomarkers to Detect PAF and to Monitor the Progression of Frequent Atrial Premature Beats to PAF", 
        "overall_contact": {
            "email": "philippah@doctors.org.uk", 
            "last_name": "Philippa J Howlett, MBChB BSc"
        }, 
        "overall_contact_backup": {
            "email": "eleatham@hasteacademy.org", 
            "last_name": "Edward W Leatham, MBChB MD"
        }, 
        "overall_official": [
            {
                "affiliation": "The Royal Surrey County Hospital", 
                "last_name": "Philippa Howlett, MBChB BSc", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "The Royal Surrey County Hospital", 
                "last_name": "Edward Leatham, MBChB MD", 
                "role": "Study Director"
            }, 
            {
                "affiliation": "The University of Surrey", 
                "last_name": "Chris Fry, BSc PhD", 
                "role": "Study Director"
            }
        ], 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United Kingdom: National Health Service", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 3", 
        "primary_completion_date": {
            "#text": "October 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "The diagnostic yield of a Personal Heart Rhythm Monitor (PHRM), used for 3 months, compared to an automated cardiac event recorder (ACER), used for 1 week, to detect all episodes of paroxysmal atrial fibrillation.", 
            "safety_issue": "No", 
            "time_frame": "18 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01867060"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "The diagnostic yield of a Personal Heart Rhythm Monitor (PHRM), used for 3 months, compared to an automated cardiac event recorder (ACER), used for 1 week, to detect prolonged episodes of paroxysmal atrial fibrillation (defined as greater than 12 hours).", 
                "safety_issue": "No", 
                "time_frame": "18 months"
            }, 
            {
                "measure": "The sensitivity and specificity of serum  biomarkers to detect cases of PAF.", 
                "safety_issue": "No", 
                "time_frame": "18 months"
            }, 
            {
                "measure": "The sensitivity and specificity of markers of left atrial function to predict PAF.", 
                "safety_issue": "No", 
                "time_frame": "18 months"
            }, 
            {
                "measure": "The development of AF in a cohort confirmed to have frequent atrial ectopic beats (APBs) over a one year period.", 
                "safety_issue": "No", 
                "time_frame": "18 months"
            }, 
            {
                "measure": "Adverse events (including stroke/TIA, myocardial infarction, significant bleeding events and death) at six and twelve month intervals.", 
                "safety_issue": "Yes", 
                "time_frame": "30 months"
            }, 
            {
                "description": "A reduction in stroke burden in the local area will be calculated from estimated stroke risk in individuals identified with AF and from a local registry.", 
                "measure": "Stroke reduction in the local area", 
                "safety_issue": "Yes", 
                "time_frame": "30 months"
            }, 
            {
                "description": "The number of referrals to secondary care for suspected PAF will be analysed.", 
                "measure": "Referrals to secondary care for suspected AF/palpitations", 
                "safety_issue": "No", 
                "time_frame": "18 months"
            }, 
            {
                "measure": "Participant satisfaction with the devices used in the study.", 
                "safety_issue": "No", 
                "time_frame": "18 months"
            }
        ], 
        "source": "University of Surrey", 
        "sponsors": {
            "collaborator": {
                "agency": "Royal Surrey County Hospital NHS Foundation Trust", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "University of Surrey", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "May 2013", 
        "study_design": "Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Diagnostic", 
        "study_type": "Interventional", 
        "verification_date": "May 2014"
    }
}